• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Theravance Biopharma, Inc. - Ordinary Shares (NQ:TBPH)

    17.03 +0.02 (+0.12%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 14, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 243,260
    Open 17.01
    Bid (Size) 17.02 (2,000)
    Ask (Size) 17.07 (600)
    Prev. Close 17.01
    Today's Range 17.01 - 17.05
    52wk Range 13.08 - 21.03
    Shares Outstanding 49,471,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its Shareholders
    From Halper Sadeh LLC
    Via Business Wire

    Performance

    YTD
    -6.2%
    -6.2%
    1 Month
    +0.4%
    +0.4%
    3 Month
    +4.4%
    +4.4%
    6 Month
    +22.3%
    +22.3%
    1 Year
    +18.3%
    +18.3%

    More News

    Read More
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
    From Pomerantz LLP
    Via GlobeNewswire
    Theravance Biopharma Inc (NASDAQ:TBPH) Shows Strong Technical and Fundamental Momentum ↗
    Via Chartmill
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    TBPH Investors Have Opportunity to Join Theravance Biopharma, Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    What's going on in today's session ↗
    Via Chartmill
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    TBPH Stock Slumps 30%, Falls Below 200-DMA For First Time In Over 9 Months As Phase 3 Study Misses Primary Endpoint ↗
    Via Stocktwits
    Topics Workforce
    Which stocks are gapping on Tuesday? ↗
    Via Chartmill
    News headline image
    Surgery Partners Stock Down 39% as One Fund Slashes Stake by $19 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Alkami Stock Down 50%, But This New $49 Million Stake Signals Conviction in a Turnaround ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Integer Holdings Lands New $99 Million Stake Even With Stock Down Over 30% This Past Year ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Fund Builds $40 Million SPS Commerce Stake as Shares Sink 60% Despite 100 Straight Growth Quarters ↗
    Via The Motley Fool
    Topics Economy Regulatory Compliance Supply Chain
    News headline image
    Vistance Networks Stock Up 250%. Here's Why a $40 Million Position Signals a Post-Divestiture Bet ↗
    Via The Motley Fool
    News headline image
    Array Stock Down 25%, But This $17.3 Million Buy Signals Confidence Amid Big Revenue Growth ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Enviri Stock Up 120% as $43 Million Buy Makes It a Top Holding in This Portfolio ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Integer Stock Down 38%, but One Fund Just Bet $40 Million on a Turnaround ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Irenic Dumps Most Papa John's Shares ↗
    Via The Motley Fool
    Topics ETFs Regulatory Compliance
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    These stocks that are showing activity before the opening bell on Friday. ↗
    Via Chartmill
    These stocks that are showing activity before the opening bell on Tuesday. ↗
    Via Chartmill
    News headline image
    Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Theravance Biopharma, Inc. - Ordinary Shares publicly traded?
    Yes, Theravance Biopharma, Inc. - Ordinary Shares is publicly traded.
    What exchange does Theravance Biopharma, Inc. - Ordinary Shares trade on?
    Theravance Biopharma, Inc. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares?
    The ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares is TBPH on the Nasdaq Stock Market
    What is the current price of Theravance Biopharma, Inc. - Ordinary Shares?
    The current price of Theravance Biopharma, Inc. - Ordinary Shares is 17.03
    When was Theravance Biopharma, Inc. - Ordinary Shares last traded?
    The last trade of Theravance Biopharma, Inc. - Ordinary Shares was at 09/14/26 04:00 PM ET
    What is the market capitalization of Theravance Biopharma, Inc. - Ordinary Shares?
    The market capitalization of Theravance Biopharma, Inc. - Ordinary Shares is 842.49M
    How many shares of Theravance Biopharma, Inc. - Ordinary Shares are outstanding?
    Theravance Biopharma, Inc. - Ordinary Shares has 842M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.